Alchemab receives funding boost for Parkinson’s research
Innovative antibody discovery could lead to new Parkinson’s treatments
Read More
Tag: Alchemab
Alchemab Therapeutics reveals Alzheimer’s candidate
ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein
Read More
Alchemab to collaborate with AstraZeneca on prostate cancer research
Collaboration will aim to improve understanding of prostate cancer and identify novel antibodies for the disease
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
